1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow Graves' Orbitopathy: new trials by email Literature Review of Graves' Orbitopathy trials Research Report on Graves' Orbitopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study Atorvastatin 20mg, Placebo - Graves' Orbitopathy | Phase 3 | Not yet recruiting | University of Pisa | 102 | 2024-01-01 | 2023-03-15 |
| A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy Methimazole, Radioiodine or thyroidectomy - Graves' Orbitopathy | Phase 3 | Unknown | University of Pisa | 52 | 2023-03-02 | 2023-03-17 |
| Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study Teprotumumab, Placebo - Thyroid Eye Disease, Graves' Orbitopathy | Phase 3 | Completed | Amgen | 83 | 2017-10-04 | 2024-07-11 |
Graves Ophthalmopathy (3) · Exophthalmos (1)
Autoimmune Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Endocrine System Diseases (3) · Eye Diseases (3) · Eye Diseases, Hereditary (3) · Genetic Diseases, Inborn (3) · Goiter (3) · Graves Disease (3) · Hyperthyroidism (3) · Immune System Diseases (3) · Orbital Diseases (3) · Thyroid Diseases (3) · Exophthalmos (2)
Atorvastatin (1) · Iodine-131 (1) · Methimazole (1) · Saline Solution (1) · Thyroidectomy (1) · teprotumumab (1)
University of Pisa (2) · Amgen (1)
Italy (3) · Germany (1) · United States (1)
2017 (1)